Login
Home
Charts
Search
Watchlist
Products

Shreeoswal Seeds & Chemicals Ltd

OSWALSEEDS·NSE
13.57-1.74%Wed, 23 Sept '26 15:50

Shreeoswal Seeds & Chemicals Ltd

OSWALSEEDS
NSE
13.57
-1.74%
|Wed, 23 Sept '26 15:50
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
124Cr
Close
Close Price
13.55
Industry
Industry
Miscellaneous
PE
Price To Earnings
10.19
PS
Price To Sales
0.46
Revenue
Revenue
267Cr
Rev Gr TTM
Revenue Growth TTM
0.16%
PAT Gr TTM
PAT Growth TTM
-9.69%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
6677437768752698395556117
Growth YoY
Revenue Growth YoY%
100.5-11.465.3-7.73.3-1.7-40.527.3-41.7-27.4116.919.5
Expenses
ExpensesCr
637848796667248743525299
Operating Profit
Operating ProfitCr
2-1-5-228211-43418
OPM
OPM%
3.7-1.6-10.7-2.62.310.87.511.4-8.95.17.215.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
122111111111
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
1-3-6-407110-51317
Tax
TaxCr
00-3-10203-1015
PAT
PATCr
1-3-4-30517-31212
Growth YoY
PAT Growth YoY%
149.2-300.0-1,426.1-234.0-50.0261.8115.7367.6-1,100.0-80.8283.668.5
NPM
NPM%
1.0-4.3-8.1-3.50.57.12.17.4-8.11.93.810.5
EPS
EPS
0.1-0.4-0.4-0.30.00.60.10.8-0.30.10.21.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
6677437768752698395556117
Growth YoY
Revenue Growth YoY%
100.5-11.465.3-7.73.3-1.7-40.527.3-41.7-27.4116.919.5
Expenses
ExpensesCr
637848796667248743525299
Operating Profit
Operating ProfitCr
2-1-5-228211-43418
OPM
OPM%
3.7-1.6-10.7-2.62.310.87.511.4-8.95.17.215.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
122111111111
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
1-3-6-407110-51317
Tax
TaxCr
00-3-10203-1015
PAT
PATCr
1-3-4-30517-31212
Growth YoY
PAT Growth YoY%
149.2-300.0-1,426.1-234.0-50.0261.8115.7367.6-1,100.0-80.8283.668.5
NPM
NPM%
1.0-4.3-8.1-3.50.57.12.17.4-8.11.93.810.5
EPS
EPS
0.1-0.4-0.4-0.30.00.60.10.8-0.30.10.21.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
18126117161241272269246248267
Growth
Revenue Growth%
605.8-7.538.249.213.2-1.2-8.60.90.2
Expenses
ExpensesCr
16120110154230260268236234246
Operating Profit
Operating ProfitCr
267810121101522
OPM
OPM%
9.84.96.04.84.44.40.43.95.98.1
Other Income
Other IncomeCr
0000000000
Interest Expense
Interest ExpenseCr
1222346455
Depreciation
DepreciationCr
0000001111
PBT
PBTCr
144588-551016
Tax
TaxCr
011122-1224
PAT
PATCr
133456-44712
Growth
PAT Growth%
152.68.119.948.95.0-172.9184.8104.6-9.7
NPM
NPM%
6.22.22.62.32.32.1-1.61.42.94.6
EPS
EPS
1.10.30.30.40.60.6-0.50.40.81.3
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
18126117161241272269246248267
Growth
Revenue Growth%
605.8-7.538.249.213.2-1.2-8.60.90.2
Expenses
ExpensesCr
16120110154230260268236234246
Operating Profit
Operating ProfitCr
267810121101522
OPM
OPM%
9.84.96.04.84.44.40.43.95.98.1
Other Income
Other IncomeCr
0000000000
Interest Expense
Interest ExpenseCr
1222346455
Depreciation
DepreciationCr
0000001111
PBT
PBTCr
144588-551016
Tax
TaxCr
011122-1224
PAT
PATCr
133456-44712
Growth
PAT Growth%
152.68.119.948.95.0-172.9184.8104.6-9.7
NPM
NPM%
6.22.22.62.32.32.1-1.61.42.94.6
EPS
EPS
1.10.30.30.40.60.6-0.50.40.81.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111515151515181818
Reserves
ReservesCr
11114182329222533
Current Liabilities
Current LiabilitiesCr
383436547781835987
Non Current Liabilities
Non Current LiabilitiesCr
210652123
Total Liabilities
Total LiabilitiesCr
52616693120128124105141
Current Assets
Current AssetsCr
4959618811512211292129
Non Current Assets
Non Current AssetsCr
325556121311
Total Assets
Total AssetsCr
52616693120128124105141
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111515151515181818
Reserves
ReservesCr
11114182329222533
Current Liabilities
Current LiabilitiesCr
383436547781835987
Non Current Liabilities
Non Current LiabilitiesCr
210652123
Total Liabilities
Total LiabilitiesCr
52616693120128124105141
Current Assets
Current AssetsCr
4959618811512211292129
Non Current Assets
Non Current AssetsCr
325556121311
Total Assets
Total AssetsCr
52616693120128124105141

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-10-10-4-11512-1524-14
Investing Cash Flow
Investing Cash FlowCr
01-30-1-2-4-1-1
Financing Cash Flow
Financing Cash FlowCr
1013410-4-717-2615
Net Cash Flow
Net Cash FlowCr
03-3-113-2-31
Free Cash Flow
Free Cash FlowCr
-10-10-6-12411-1824
CFO To PAT
CFO To PAT%
-853.5-365.5-125.6-296.798.2208.3368.3683.0-189.9
CFO To EBITDA
CFO To EBITDA%
-543.3-165.2-54.8-141.250.999.8-1,523.4251.7-94.3
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-10-10-4-11512-1524-14
Investing Cash Flow
Investing Cash FlowCr
01-30-1-2-4-1-1
Financing Cash Flow
Financing Cash FlowCr
1013410-4-717-2615
Net Cash Flow
Net Cash FlowCr
03-3-113-2-31
Free Cash Flow
Free Cash FlowCr
-10-10-6-12411-1824
CFO To PAT
CFO To PAT%
-853.5-365.5-125.6-296.798.2208.3368.3683.0-189.9
CFO To EBITDA
CFO To EBITDA%
-543.3-165.2-54.8-141.250.999.8-1,523.4251.7-94.3

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
431752354342,47526610695124
Price To Earnings
Price To Earnings
15.111.512.916.086.829.913.210.2
Price To Sales
Price To Sales
0.31.51.51.89.11.00.40.40.5
Price To Book
Price To Book
1.61.21.42.311.26.62.41.92.4
EV To EBITDA
EV To EBITDA
10.029.236.245.3210.8325.115.56.96.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.06.98.46.85.96.32.36.0
OPM
OPM%
9.84.96.04.84.44.40.43.95.98.1
NPM
NPM%
6.22.22.62.32.32.1-1.61.42.94.6
ROCE
ROCE%
5.412.211.29.812.713.60.610.924.924.9
ROE
ROE%
9.410.610.311.014.112.9-10.38.114.214.2
ROA
ROA%
2.14.64.63.94.54.5-3.43.45.15.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
431752354342,47526610695124
Price To Earnings
Price To Earnings
15.111.512.916.086.829.913.210.2
Price To Sales
Price To Sales
0.31.51.51.89.11.00.40.40.5
Price To Book
Price To Book
1.61.21.42.311.26.62.41.92.4
EV To EBITDA
EV To EBITDA
10.029.236.245.3210.8325.115.56.96.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.06.98.46.85.96.32.36.0
OPM
OPM%
9.84.96.04.84.44.40.43.95.98.1
NPM
NPM%
6.22.22.62.32.32.1-1.61.42.94.6
ROCE
ROCE%
5.412.211.29.812.713.60.610.924.924.9
ROE
ROE%
9.410.610.311.014.112.9-10.38.114.214.2
ROA
ROA%
2.14.64.63.94.54.5-3.43.45.15.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Shreeoswal Seeds & Chemicals is an Indian agro-commodities company built on a simple, recurring idea: take a raw agricultural product, process it in-house, and sell it into global markets where demand is steady and growing. It began as a partnership in 2002 in Neemuch, Madhya Pradesh, and became a public company in 2017, evolving from a traditional seed processor into a diversified player with two distinct engines. That original idea - own the processing, control the quality, and reach the customer directly - now repeats across both its seeds and psyllium businesses. # Business segments Two engines built on the same playbook - a seed-processing core that anchors the group, and a psyllium business that has grown to become its largest revenue driver, each run through its own processing facility and legal entity. ## 1. Seeds: the original processing anchor **The company cleans, grades and trades agricultural seeds from a single owned plant, serving a farming economy that feeds 2.5 billion people.** - **A single processing hub** - all seed products are processed at the company’s own facility in Neemuch, Madhya Pradesh. Owning the plant means the company controls throughput and quality rather than relying on third-party processors. - **Inventory is the working capital engine** - as of March 2025, finished goods made up Rs. 2,268 Lakhs of the Rs. 2,389 Lakhs in total inventories, with the entire stock pledged to secure working capital facilities. This is a business that ties up cash in seed stock before it is sold, so access to bank funding against that stock is what keeps the cycle turning. - **R&D is now in-house** - the company received three-year recognition for its in-house R&D unit from the Department of Scientific and Industrial Research, Government of India, in FY25. That lets it develop its own seed varieties rather than just trading what others produce, and it had already announced plans to enter vegetable seeds. - **Customer risk sits in the soil** - the company faces legal claims from farmers when seeds fail to germinate, though it notes that causes can include climate, soil, water or farmer error rather than seed quality alone. This is a structural feature of the seed business: the product is alive, and outcomes are never fully in the seller’s control. ## 2. Psyllium: the high-growth export engine **Psyllium husk is processed and traded through a wholly owned subsidiary that has scaled to become the group’s largest segment by revenue.** - **A separate legal entity with its own plant** - the psyllium business runs through Shreeoswal Psyllium Exports India Limited, a wholly owned subsidiary incorporated in 2018 that operates its own processing unit. This structure isolates the psyllium operations and lets the subsidiary raise its own equity, as it did through a Rs. 6 Crore rights issue in 2024 that the parent fully subscribed. - **Parent funding fuels the subsidiary** - beyond equity, the parent has extended unsecured loans to the subsidiary, with Rs. 758.84 Lakhs outstanding as of March 2025, used for the subsidiary’s principal business activities. The parent also provided a corporate guarantee of Rs. 55.86 Lakhs, backing the subsidiary’s obligations. - **Built from a partnership foundation** - the subsidiary began life as a partnership firm, ‘M/s Oswal Psyllium Exports’, registered in December 2007, before converting to a public limited company in February 2018. That means the psyllium expertise predates the corporate structure by over a decade - the company was trading psyllium long before it became a formal segment. - **India’s psyllium advantage** - psyllium husk is a fibre used in laxatives and health foods, and India is its dominant global producer. The company does not disclose export volumes, but the subsidiary’s turnover was already Rs. 15,791 Lakhs as of March 2023, and the segment now accounts for roughly 30% of consolidated revenue. The business carries no foreign exchange exposure and does not hedge, suggesting it invoices in rupees or passes currency risk to buyers. # Group structure and partners **The company operates through a parent-subsidiary structure with two reportable segments, while a related ethanol entity creates a new revenue stream from FY26.** - **Consolidated reporting, standalone simplicity** - on a consolidated basis the company reports two segments, Seed and Psyllium; on a standalone basis the parent has no reportable segments, meaning all operating activity sits in the subsidiary. The parent is effectively a holding company for the seed business and the investment in psyllium. - **Promoter control is concentrated** - as of March 2024, Mr. Anil Kumar Nahata and Mr. Sanjay Kumar Baigani each held 34.99% of the company, giving the two founders combined control of nearly 70%. The board of eight directors is chaired by Mr. Sanjay Kumar Begani as Chairman & Managing Director. - **A related ethanol entity brings new optionality** - Oswal Ethanol and Feed Industry Private Limited, a group company, has received a Rs. 110 Crore corporate guarantee from Shreeoswal and its subsidiary, secured against the company’s own property. In return, Shreeoswal has obtained the first right of refusal for Distiller’s Dried Grains with Solubles (DDGS) - a high-protein animal feed by-product of ethanol production - effective from FY26. This is a capital-light way to add a third product line without building its own ethanol plant.

Documents — Shreeoswal Seeds & Chemicals Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/8am0pxtayd6talq3e3e5w0ub.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/newhc9s6vcqhq1to9t03h6qn.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/71r3g80uqxqj5agkjkwokger.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/w60qtv5decer5bq2vidw1dy7.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/evyki3sf8tqn4yhf48e05hyh.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/5g0gweknrei6vbuuutd7lbmd.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/2zcmuace2b24ldkjpoctr8zf.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/yaor5xaeonmrk0wqe7rcxh4j.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ffftvz4otk9pwd5lz0c0skhd.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/pmofllormb9sibqujcns8pat.pdf